| Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants LC Tsoi, PE Stuart, C Tian, JE Gudjonsson, S Das, M Zawistowski, ... Nature communications 8 (1), 15382, 2017 | 334 | 2017 |
| Clinical and genetic differences between pustular psoriasis subtypes S Twelves, A Mostafa, N Dand, E Burri, K Farkas, R Wilson, HL Cooper, ... Journal of allergy and clinical immunology 143 (3), 1021-1026, 2019 | 205 | 2019 |
| Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 171 | 2021 |
| An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target SK Mahil, M Catapano, P Di Meglio, N Dand, H Ahlfors, IM Carr, CH Smith, ... Science translational medicine 9 (411), eaan2514, 2017 | 147 | 2017 |
| HLA-C* 06: 02 genotype is a predictive biomarker of biologic treatment response in psoriasis N Dand, M Duckworth, D Baudry, A Russell, CJ Curtis, SH Lee, I Evans, ... Journal of Allergy and Clinical Immunology 143 (6), 2120-2130, 2019 | 142 | 2019 |
| Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and … SK Mahil, N Wilson, N Dand, NJ Reynolds, CEM Griffiths, R Emsley, ... British Journal of Dermatology 182 (5), 1158-1166, 2020 | 117 | 2020 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 106 | 2021 |
| Psoriasis and genetics N Dand, SK Mahil, F Capon, CH Smith, MA Simpson, JN Barker Acta Derm Venereol 100 (3), 00015555-3384, 2020 | 105 | 2020 |
| Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02 C Tziotzios, C Petridis, N Dand, C Ainali, JR Saklatvala, V Pullabhatla, ... Nature communications 10 (1), 1150, 2019 | 93 | 2019 |
| Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk JG Pouget, ... Human Molecular Genetics 28 (20), 3498-3513, 2019 | 79 | 2019 |
| Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis J Bowes, J Ashcroft, N Dand, F Jalali-Najafabadi, E Bellou, P Ho, ... Annals of the rheumatic diseases 76 (10), 1774-1779, 2017 | 74 | 2017 |
| Defining the therapeutic range for adalimumab and predicting response in psoriasis: a multicenter prospective observational cohort study N Wilkinson, T Tsakok, N Dand, K Bloem, M Duckworth, D Baudry, ... Journal of Investigative Dermatology 139 (1), 115-123, 2019 | 70 | 2019 |
| Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling N Dand, S Mucha, LC Tsoi, SK Mahil, PE Stuart, A Arnold, H Baurecht, ... Human molecular genetics 26 (21), 4301-4313, 2017 | 51 | 2017 |
| Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne C Petridis, AA Navarini, N Dand, J Saklatvala, D Baudry, M Duckworth, ... Nature communications 9 (1), 5075, 2018 | 50 | 2018 |
| Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression S Mucha, H Baurecht, N Novak, E Rodríguez, S Bej, G Mayr, H Emmert, ... Journal of Allergy and Clinical Immunology 145 (4), 1208-1218, 2020 | 42 | 2020 |
| Genome-wide pathway analysis identifies genetic pathways associated with psoriasis A Aterido, A Julià, C Ferrándiz, L Puig, E Fonseca, E Fernández-López, ... Journal of Investigative Dermatology 136 (3), 593-602, 2016 | 40 | 2016 |
| Association of serum ustekinumab levels with clinical response in psoriasis T Tsakok, N Wilson, N Dand, FC Loeff, K Bloem, D Baudry, M Duckworth, ... JAMA dermatology 155 (11), 1235-1243, 2019 | 39 | 2019 |
| Biomarkers of disease progression in people with psoriasis: a scoping review R Ramessur, M Corbett, D Marshall, ML Acencio, IA Barbosa, N Dand, ... British Journal of Dermatology 187 (4), 481-493, 2022 | 37 | 2022 |
| Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey SK Mahil, M Yates, SM Langan, ZZN Yiu, T Tsakok, N Dand, KJ Mason, ... British Journal of Dermatology 185 (1), 80-90, 2021 | 31 | 2021 |
| Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis R Andres-Ejarque, HB Ale, K Grys, I Tosi, S Solanky, C Ainali, Z Catak, ... Nature communications 12 (1), 4741, 2021 | 26 | 2021 |
